>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
缺血修饰白蛋白在急性冠脉综合征中的研究进展
作者:章延春1  张荣林2  王万虹2 
单位:1. 南京医科大学,江苏 南京 210008;
2. 南京大学医学院附属鼓楼医院 心血管内科,江苏 南京 210008
关键词:缺血修饰白蛋白 急性冠脉综合征 心肌缺血标记物 文献综述 
分类号:R543.3
出版年·卷·期(页码):2012·31·第五期(657-660)
摘要:

急性冠脉综合征(acute coronary syndrome,ACS)是临床常见的心血管急症。传统的生化标记物均在心肌组织坏死后才释放入血液中,而缺血修饰白蛋白(ischemia modified albumin,IMA)能在心肌发生缺血时即升高,进一步的研究证实IMA是心肌缺血标记物而非心肌损伤标记物,在ACS患者的早期诊断、危险分层和预后评估中具有重要意义。作者对IMA的形成机制、检测原理及其在ACS中临床应用的最新进展予以综述。

参考文献:

[1] COLLINSON P O,GAZE D C.Biomarkers of cardiovascular damage[J].Med Princ Pract,2007,16(4):247-261.
[2] BAR-OR D,CURTIS G,RAO N,et al.Characterization of the Co(2+)and Ni(2+) binding amino-acid residues of the N-terminus of human albumin[J].Eur J Biochem,2001,268(1):42-47.
[3] ROY D,QUILES J,GAZE D C,et al.Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin[J].Heart,2006,92(1):113-114.
[4] CHRISTENSON R H,DUH S H,SANHAI W R,et al.Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients:a multicenter study[J].Clin Chem,2001,47(3):464-470.
[5] BAR-OR D,MELDRUM D R,SEHIEFER B.A novel assay for cobalt albumin binding and its potential as a marker for myocardial ischemia a preliminary report[J].J Emerg Med,2000,19(4):311-315.
[6] MAGUIRE O C,O’SULLIVAN J,RYAN J,et al.Evaluation of the albumin cobalt binding(ACB) assay for measurement of ischaemia modified albumin(IMA) on the Beckman Coulter LX220[J].Ann Clin Biochem,2006,43(6):494-499.
[7] HAUSEN B S,SIGNOR C,KOBER H,et al.Effect of temperature on albumin cobalt binding and its influence on ischemia-modified albumin levels in patients with suspected acute coronary syndrome[J].Clin Lab,2012,58(1-2):169-172.
[8] CHO D K,CHOI J O,KIM S H,et al.Ischemia modified albumin is a highly sensitive serum marker of transient myocardial ischemia induced by coronary vasospasm1[J].Coron Artery Dis,2007,18:83-87.
[9] QUILES J,ROY D,GAZE D,et al.Relation of ischemia modified albumin(IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon induced myocardial ischemia[J].Am J Cardiol,2003,92:322-324.
[10] HJORTSHOJ S P,DETHLEFSEN C,KRISTENSEN S R,et al.Kinetics of ischemia modified albumin during ongoing severe myocardial ischemia[J].Clin Chim Acta,2009,403(1-2):114-120.
[11] SBAROUNI E,GEORGIADOU P,PANAGIOTAKOS D,et al.Ischemia modified albumin in radiofrequency catheter ablation[J].Europace,2007,9(2):127-129.
[12] SBAROUNI E,GEORGIADOU P,PANAGIOTAKOS D,et al.The ischemia modified albumin in relation to pacemaker and defibrillator implantation[J].Pacing Clin Elect Rophysiol,2008,31(1):83-87.
[13] BHAGAVAN N V,LAI E M,RIOS P A,et al.Evaluation of human serum albumin cobalt assay for the assessment of myocardial ischemia and myocardial infarction[J].Clin Chem,2003,49:581-585.
[14] SINHA M K,ROY D,GAZE D C,et al.Role of "Ischemia Modified Albumin",a new biochemical marker of myocardial ischemia,in the early diagnosis of acute coronary syndromes[J].Emerg Med J,2004,21(1):29-34.
[15] PEACOCK F,MORRIS D L,ANWARUDDIN S.Meta analysis of ischemia modified albumin to rule out acute coronary syndromes in the emergency department[J].Am Heart J,2006,152(2):253-262.
[16] TALWALKAR S S,BON-HOMME M,MILLER J J,et al.Ischemia modified albumin,a marker of acute ischemic events: a pilot study[J].Ann Clin Lab Sci,2008,38(2):132-137.
[17] LIYAN C,JIE Z,XIAOZHOU H.Prognostic value of combination of Heart-type fatty acid-binding protein and ischemia-modified albumin in patients with acute coronary syndromes and normal troponin T values[J].J Clin Lab Anal,2009,23(1):14-18.
[18] LEE Y W,KIM H J,CHO Y H,et al.Application of albumin adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome[J].Clin Chim Acta,2007,384(1-2):24-27.
[19] 佘吉佳.联合检测血生化标志物对急性心肌梗死的诊断价值[J].现代医学,2010,37(2):172-174.
[20] BHARDWAJ A,TRUONG Q A,PEACOCK W F,et al.A multicenter comparison of established and emerging cardiac biomarkers for the diagnostic evaluation of chest pain in the emergency department[J].Am Heart J,2011,162(2):276-282.
[21] POLLACK C V Jr,PEACOCK W F.Ischemia modified albumin(IMA) is useful in risk stratification of emergency department chest pain patients[J].Acad Emerg Med,2003,10(5):555-556.
[22] DUSEK J,TICHY M,STASEK J,et al.Ischemia modified albumin: a new marker of myocardial ischemial[J].Cas Lek Cesk,2005,144:295-297.
[23] WORSTER A,DEVERAUX P J,HEELS-ANSDELL D,et al.Capability of ischemia modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome[J].CMAJ,2005,172(13):1685-1690.
[24] APARCI M,KARDESOGLU E,OZMEN N,et al.Prognostic significance of ischemia modified albumin in patients with acute coronary syndrome[J].Coron Artery Dis,2007,18(5):367-373.
[25] BALI L,CUISSET T,GIORGI R,et al.Prognostic value of ischemia modified albumin in patients with non-ST-segment elevation acute coronary syndromes[J].Arch Cardiovasc Dis,2008,101(10):645-651.
[26] DOMINGUEZ R A,KASKI J C,ABREU-GONZALEZ P,et al.Role of ischemia modified albumin to ST-segment resolution after mechanical reperfusion in patients with ST-segment elevation myocardial infarction[J].Atherosclerosis,2009,203(2):576-580.
[27] DOMINGUEZ A,ABREU P,GARCIA M J,et al.Relation of ischemia modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention[J].Clin Chim Acta,2008,388(1-2):196-199.
[28] SBAROUNI E,GEORGIADOU P,VOUDRIS V,et al.Ischemia modified albumin changes-review and clinical implications[J].Clin Chem Lab Med,2011,49(2):177-184.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 410547 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364